127 related articles for article (PubMed ID: 30926056)
1. Depicting distant metastatic risk by refined subgroups derived from the 8th edition nasopharyngeal carcinoma TNM.
Guo Q; Lu T; Hui Huang S; O'Sullivan B; Zong J; Xiao Y; Xu W; Chen C; Qiu S; Xu L; Zheng W; Chen Y; Lin S; Pan J
Oral Oncol; 2019 Apr; 91():113-120. PubMed ID: 30926056
[TBL] [Abstract][Full Text] [Related]
2. Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
Huang CL; Guo R; Li JY; Xu C; Mao YP; Tian L; Lin AH; Sun Y; Ma J; Tang LL
Eur Radiol; 2020 Feb; 30(2):816-822. PubMed ID: 31650266
[TBL] [Abstract][Full Text] [Related]
3. Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein-Barr virus DNA level in a non-Chinese population: secondary analysis from a prospective randomized trial.
Kitpanit S; Jittapiromsak N; Sriyook A; Prayongrat A; Kannarunimit D; Chakkabat C; Lertbutsayanukul C
Jpn J Clin Oncol; 2019 Dec; 49(12):1100-1113. PubMed ID: 31334768
[TBL] [Abstract][Full Text] [Related]
4. Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era.
Tang LL; Chen YP; Mao YP; Wang ZX; Guo R; Chen L; Tian L; Lin AH; Li L; Sun Y; Ma J
J Natl Compr Canc Netw; 2017 Jul; 15(7):913-919. PubMed ID: 28687579
[No Abstract] [Full Text] [Related]
5. Assessment of Survival Model Performance Following Inclusion of Epstein-Barr Virus DNA Status in Conventional TNM Staging Groups in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma.
Li WZ; Wu HJ; Lv SH; Hu XF; Liang H; Liu GY; Lu N; Bei WX; Lv X; Guo X; Xia WX; Xiang YQ
JAMA Netw Open; 2021 Sep; 4(9):e2124721. PubMed ID: 34554238
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
[TBL] [Abstract][Full Text] [Related]
7. An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.
Chan SK; O'Sullivan B; Huang SH; Chau TC; Lam KO; Chan SY; Tong CC; Vardhanabhuti V; Kwong DL; Ng CY; Leung TW; Luk MY; Lee AW; Choi HC; Lee VH
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454830
[TBL] [Abstract][Full Text] [Related]
8. Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic cases.
Chen FP; Lin L; Liang JH; Tan SH; Ong EHW; Luo YS; Huang L; Sim AYL; Wang HT; Gao TS; Deng B; Zhou GQ; Kou J; Chua MLK; Sun Y
Ther Adv Med Oncol; 2021; 13():17588359211052417. PubMed ID: 34721672
[TBL] [Abstract][Full Text] [Related]
9. Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up.
Wu LR; Zhang XM; Xie XD; Lu Y; Wu JF; He X
Oral Oncol; 2019 Nov; 98():141-146. PubMed ID: 31586896
[TBL] [Abstract][Full Text] [Related]
10. The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
Lee VH; Kwong DL; Leung TW; Choi CW; O'Sullivan B; Lam KO; Lai V; Khong PL; Chan SK; Ng CY; Tong CC; Ho PP; Chan WL; Wong LS; Leung DK; Chan SY; So TH; Luk MY; Lee AW
Int J Cancer; 2019 Apr; 144(7):1713-1722. PubMed ID: 30192385
[TBL] [Abstract][Full Text] [Related]
11. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
[TBL] [Abstract][Full Text] [Related]
12. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
[TBL] [Abstract][Full Text] [Related]
13. Validation and suggestion of eighth T classifications of the UICC/AJCC staging system for nasopharyngeal carcinoma patients: a retrospective analysis.
Li Y; Ou X; Hu C
Jpn J Clin Oncol; 2018 Oct; 48(10):927-933. PubMed ID: 30113640
[TBL] [Abstract][Full Text] [Related]
14. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
Pan JJ; Ng WT; Zong JF; Lee SW; Choi HC; Chan LL; Lin SJ; Guo QJ; Sze HC; Chen YB; Xiao YP; Kan WK; O'Sullivan B; Xu W; Le QT; Glastonbury CM; Colevas AD; Weber RS; Lydiatt W; Shah JP; Lee AW
Cancer; 2016 Nov; 122(21):3307-3315. PubMed ID: 27434142
[TBL] [Abstract][Full Text] [Related]
15. Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.
Zhang Y; Li WF; Mao YP; Zhou GQ; Peng H; Sun Y; Liu Q; Chen L; Ma J
Oncotarget; 2016 Mar; 7(12):13612-20. PubMed ID: 26871291
[TBL] [Abstract][Full Text] [Related]
16. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
Pan JJ; Ng WT; Zong JF; Chan LL; O'Sullivan B; Lin SJ; Sze HC; Chen YB; Choi HC; Guo QJ; Kan WK; Xiao YP; Wei X; Le QT; Glastonbury CM; Colevas AD; Weber RS; Shah JP; Lee AW
Cancer; 2016 Feb; 122(4):546-58. PubMed ID: 26588425
[TBL] [Abstract][Full Text] [Related]
17. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system.
Zong J; Lin S; Lin J; Tang L; Chen B; Zhang M; Zhang Y; Xu L; Chen Y; Xiao Y; Fang Y; Pan J
Oral Oncol; 2015 Mar; 51(3):254-9. PubMed ID: 25467207
[TBL] [Abstract][Full Text] [Related]
18. Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
Kang M; Zhou P; Li G; Yan H; Feng G; Liu M; Zhu J; Wang R
Oncotarget; 2017 Sep; 8(41):70586-70594. PubMed ID: 29050304
[TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal carcinoma in a non-endemic country-Validation of the new NPC staging system.
Rodrigues Dias D; Breda E; Sousa F; Soares A; Monteiro E
Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(1):39-49. PubMed ID: 36858784
[TBL] [Abstract][Full Text] [Related]
20. A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.
Li J; Zou X; Wu YL; Guo JC; Yun JP; Xu M; Feng QS; Chen LZ; Bei JX; Zeng YX; Chen MY
PLoS One; 2014; 9(12):e116261. PubMed ID: 25536307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
